Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

Officials with Arvinas, a New Haven-based biotechnology firm, announced Thursday that the company is laying off 131 workers at the end of June, including 92 in Connecticut. The company announced ...

Lately in the Boston life sciences industry, a Newton biotech cut 20% of its workforce, Novartis signed a deal with a Waltham ...

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from ...

Even with the layoffs, the unemployment rate for biotech in April was just 2.8%, according to the Bureau of Labor Statistics.

The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...

Headed up by former Merck & Co. executive Roger Perlmutter, M.D., Ph.D., the biotech went on to secure a series of megarounds, with the most ambitious being a $517 million series B in 2022 and the ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they ...

Massachusetts’ biotech workforce remained relatively stagnant last year, following several years of slowing growth, according to data released Tuesday by MassBioEd, an industry group focused on ...

The global biotechnology market stands poised to reach an unprecedented $5.85 trillion by 2034. The compound annual growth of ...